Olink® Explore HT is a cutting-edge solution transforming the landscape of biomarker discovery. With remarkable specificity and scalability, it’s designed to enable an understanding of diseases at the protein level. Let’s delve deeper into this groundbreaking tool. Olink Explore HT: Specificity and Scalability Unmatched Specificity With Olink Explore HT, the specificity in protein measurement takes […]
Partnerships
Sampled Named a Certified Service Provider for PacBio
Sampled Named a Certified Service Provider for PacBio Piscataway, NJ, July 11, 2023 – Sampled1 today announced that it has been named a Certified Service Provider for PacBio, a leading developer of high-quality, highly accurate sequencing solutions, equipping Sampled to deliver the highest quality advanced sequencing technology services on PacBio’s technology. To achieve this certification, […]
Sampled Named Twist Bioscience ProLab
Piscataway, NJ, 2023 – Sampled1 today announced that it has been named a Next-Generation Sequencing (NGS) ProLab for Twist Bioscience, a leading synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. As an NGS ProLab, Sampled can provide researchers and scientists with access to Twist […]
Sampled’s Genomics Laboratory in Glasgow Launches Inaugural Project with Guardant Health
Glasgow lab will manage blood samples for the Guardant Health SHIELD lung cancer screening study in the EU. February 1, 2023 – Piscataway, NJ – Sampled1 today announced that the new genomics Sampled Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, to manage blood […]
Sampled at ISBER 2022
Sampled is honored to be presenting 4 talks and a poster at ISBER 2022. Take a sneak peak at the topics we will be covering at ISBER from innovative Biobanking strategies to generating high quality iPSC cell lines.